繁体中文
设为首页
加入收藏

TussiCaps缓释胶囊

2011-03-16 11:50:19  作者:新特药房  来源:中国新特药网天津分站  浏览次数:159  文字大小:【】【】【
简介: 制造商: Mallinckrodt公司 药理分类: 镇咳+抗组织胺 活性成分(补): 酒石酸氢可酮10毫克,扑尔敏8mg,正如polistirex;分机- REL的上限;含有酒精。 另外: TUSSICAPS 5mg/4mg 酒石酸氢可酮5毫克,扑 ...

制造商:
Mallinckrodt公司

药理分类:
镇咳+抗组织胺

活性成分(补):
酒石酸氢可酮10毫克,扑尔敏8mg,正如polistirex;分机- REL的上限;含有酒精。

另外:
TUSSICAPS 5mg/4mg
酒石酸氢可酮5毫克,扑尔敏4毫克,正如polistirex;分机- REL的上限;含有酒精。
指示(补):
咳嗽及上呼吸道症状。

药理作用:
TussiCaps结合阿片类镇痛药,二氢,与H1受体拮抗剂扑尔敏。氢可酮是一种镇痛药,镇咳,中枢神经系统的影响及半合成可待因的衍生物。氯苯那敏是一个具有抗胆碱能和镇静活性抗组织胺剂。它可以防止毛细血管扩张释放并导致呼吸道粘膜水肿组胺。


法律分类:
CIII

成人:
一帽(10mg/8mg)每12小时,最大:2caps/24hrs。

儿童:
<6yrs:见禁忌症。 6 - 11yrs:1帽(5mg/4mg)每12小时,最大:2caps/24hrs。

禁忌(补):
儿童<6yrs岁(致命的呼吸抑制的风险)。


警告/注意事项:
呼吸抑制。后运。肺部疾病。头部受伤。颅内压增高。青光眼。哮喘。 GI或顾阻塞。急腹症。严重肝或肾功能损害。甲状腺功能减退。阿狄森氏病。老人。虚弱。劳动和交付。妊娠(Cat.C)。哺乳母亲:不推荐。

互动(补):
中枢神经系统抑郁症,酒精添加剂,其他中枢神经系统抑制剂,三环抗抑郁药,单胺氧化抑制剂。麻痹性肠梗阻并发抗胆碱能药物。

不良反应(补):
恶心,呕吐,中枢神经系统和呼吸抑制,输尿管,膀胱括约肌痉挛,胸闷,滥用的可能性,抗胆碱作用,皮疹,搔痒。


如何提供:
帽- 20,100


最后更新:
2009年1月15日

 

TUSSICAPS 10MG/8MG

Manufacturer:

Mallinckrodt, Inc.

Pharmacological Class:

Antitussive + antihistamine

Active Ingredient(s):

Hydrocodone bitartrate 10mg, chlorpheniramine maleate 8mg; as polistirex; ext-rel caps; contains alcohol.

Also:

TUSSICAPS 5mg/4mg
Hydrocodone bitartrate 5mg, chlorpheniramine maleate 4mg; as polistirex; ext-rel caps; contains alcohol.


Indication(s):

Cough and upper respiratory symptoms.

Pharmacology:

TussiCaps combines the opioid analgesic, hydrocodone, with the H1 receptor antagonist, chlorpheniramine. Hydrocodone is a semi-synthetic codeine derivative with analgesic, antitussive, and CNS effects. Chlorpheniramine is an antihistamine agent with anticholinergic and sedative activity. It prevents released histamine from dilating capillaries and causing edema of the respiratory mucosa.

Legal Classification:

CIII

Adults:

1 cap (10mg/8mg) every 12hrs; max: 2caps/24hrs.

Children:

<6yrs: see Contraindications. 6–11yrs:1 cap (5mg/4mg) every 12hrs; max: 2caps/24hrs.

Contraindication(s):

Children <6yrs of age (risk of fatal respiratory depression).

Warnings/Precautions:

Respiratory depression. Post-op. Pulmonary disease. Head injury. Increased intracranial pressure. Glaucoma. Asthma. GI or GU obstruction. Acute abdomen. Severe hepatic or renal impairment. Hypothyroidism. Addison’s disease. Elderly. Debilitated. Labor & delivery. Pregnancy (Cat.C). Nursing mothers: not recommended.

Interaction(s):

Additive CNS depression with alcohol, other CNS depressants, tricyclic antidepressants, MAOIs. Paralytic ileus with concurrent anticholinergics.

Adverse Reaction(s):

Nausea, vomiting, CNS and respiratory depression, ureteral and vesical sphincter spasm, chest tightness, abuse potential, anticholinergic effects, rash, pruritis.

How Supplied:

Caps—20, 100

责任编辑:admin


相关文章
 

最新文章

更多

· 吡非尼酮片Pirespa(Pirf...
· 索雷尔注射剂Xolair(Oma...
· 氨来占诺片剂(Amlexano...
· 塞曲司特片/颗粒(seratr...
· TUDORZA/ PRESSAIR(acli...
· 喘乐宁(沙丁胺醇吸入剂...
· 沙丁胺醇气雾剂|Ventodi...
· AEROLIN DISKUS(硫酸沙...
· 塞曲司特|seratrodast(...
· 甲磺司特胶囊(Suplatas...

推荐文章

更多

· 吡非尼酮片Pirespa(Pirf...
· 索雷尔注射剂Xolair(Oma...
· 氨来占诺片剂(Amlexano...
· 塞曲司特片/颗粒(seratr...
· TUDORZA/ PRESSAIR(acli...
· 喘乐宁(沙丁胺醇吸入剂...
· 沙丁胺醇气雾剂|Ventodi...
· AEROLIN DISKUS(硫酸沙...
· 塞曲司特|seratrodast(...
· 甲磺司特胶囊(Suplatas...

热点文章

更多